02281oam 2200577 450 991070814110332120160303084718.0(CKB)3710000000698364(OCoLC)826648256(EXLCZ)99371000000069836420130204d2013 ua 0engurbn||||a||||txtrdacontentcrdamediacrrdacarrierPolicy implications of pharmaceutical importation for U.S. consumers hearing before the Subcommittee on Interstate Commerce, Trade, and Tourism of the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Tenth Congress, first session, March 7, 2007Washington :U.S. G.P.O.,2013.1 online resource (iii, 111 pages) illustrationsS. hrg. ;110-1189Title from title screen (viewed February 4, 2013).Paper version available for sale by the Superintendent of Documents, United States Government Printing Office.Policy Implications of Pharmaceutical Importation for U.S. ConsumersDrugsPurchasingUnited StatesDrugsPricesUnited StatesPrescription pricingUnited StatesPharmaceutical industryUnited StatesDrug reimportationGovernment policyUnited StatesInternet pharmaciesGovernment policyUnited StatesConsumer protectionUnited StatesForeign trade regulationUnited StatesPharmaceutical policyUnited StatesDrugsPurchasingDrugsPricesPrescription pricingPharmaceutical industryDrug reimportationGovernment policyInternet pharmaciesGovernment policyConsumer protectionForeign trade regulationPharmaceutical policyGPOGPOGPOOCLCQOCLCOGPOBOOK9910708141103321Policy implications of pharmaceutical importation for U.S. consumers3506407UNINA